Drug-induced blood dyscrasias with onset of respiratory symptoms
Farmaceuticos Comunitarios
; 14(2):40-45, 2022.
Article
in Spanish
| Web of Science | ID: covidwho-1929087
ABSTRACT
A patient, diagnosed with ulcerative colitis and rheumatoid arthritis and treated with mesalazine and hydroxychloroquine, presented with symptoms of catarrh similar to those of COVID-19. The pharmacotherapeutic monitoring service (PMS) provided to the patient allowed us to associate these symptoms with a side effect of the drug taken by the patient, i.e., blood dyscrasias. The intervention, carried out to inform the doctor while the patient was symptomatic, allowed the HCP to modify the treatment by reducing the doses of the drugs used until the condition was under control.
Full text:
Available
Collection:
Databases of international organizations
Database:
Web of Science
Language:
Spanish
Journal:
Farmaceuticos Comunitarios
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS